AT FRAMINGHAM, MASSACHUSETTS, the Na-±\. tional Heart Institute has been following 5,127 men and women aged 30 to 60 years in a study of factors related to the development of coronary heart disease (CHD) and hypertension. Data for a decade of follow-up studies of this population are available for analysis.
population at risk of developing the disease. Thus there were 5,127 persons free of coronary heart disease included in the final Study group (Table 1) .
These persons have been re-examined every 2 years at the clinic of the National Heart Institute in Framingham. Participants have been subjected to a comprehensive cardiovascular examination that included a detailed cardiovascular history and physical examination, a 13-lead electrocardiogram, chest X ray, and a variety of biochemical laboratory examinations, among other procedures.
The subjects of the study have been kept under close medical surveillance. All records of admissions of participants to the local hospital have been reviewed by the study personnel. Death certificates, medical examiners' reports, and any other information regarding the circumstances of death of the study subjects have been carefully evaluated. Postmortem evidence, when available, has been considered. Information concerning the health of subjects who, for one reason or another have missed an examination, has been routinely obtained from spouses, relatives, and friends. Physicians, knowing of the interest in subjects of the study, have been helpful and cooperative in providing interim information concerning the acute phase of illnesses. As a result, less than 1% of the study group have been completely lost to follow-up ( Figure 1) . Details of the sampling, All lipid determinations were done under the supervision of a biochemist in the Framingham Study laboratory, except for the beta-lipoprotein fractions. These were done on refrigerated sera at the Donner laboratory under the supervision of Dr. John Gofman who first perfected the method of ultracentrifugal separation of the beta-lipoprotein fractions (4). The total serum cholesterol determination was done using the Abell method (5). Phospholipid determinations were done using the method of Youngburg and Youngburg (6, 7).
All of the lipid determinations except the beta-lipoprotein determinations were done at each biennial examination. The diagnostic categories of coronary heart disease under consideration include angina pectoris, coronary insufficiency, myocardial infarction, and sudden unexpected death occurring in a matter of minutes without other apparent cause. Detailed criteria for each of these diagnostic categories have been published in previous reports (2). A diagnosis of angina pectoris was made only when two observers could readily agree as to its presence. Coronary insufficiency was diagnosed only in the presence of transient "ischemic" electrocardiographic changes in a setting of ischemic chest pain of prolonged nature. Myocardial infarction was designated only in those instances where development of definite electrocardiographic evidence of myocardial necrosis or the occurrence of diagnostic transient elevation of serum glutamic oxalacetic transaminase (SGOT) or lactic dehydrogenase enzyme levels could be demonstrated.
The distribution of each of the lipids under consideration in the study population was determined, and the population was then divided into four equal groups (quartiles) according to the rank of each individual in each distribution. The predictive value of each lipid could then be determined by measuring the steepness of the gradient of risk of developing coronary heart disease associated with the four quartiles, going from lowest to highest. This basis for comparison was adopted since no definite "abnormal" levels of any of the lipids could be established, and the analysis of risk of developing coronary heart disease in association with each lipid revealed no discernible "break-point" or "critical level" at which there could be demonstrated a sharp change in the rate of development of disease.
The risk of developing coronary heart disease was assessed for each set of quartiles of the distribution of the following lipids and lipid indexes: [1] The risk of developing coronary heart disease was expressed as a morbidity ratio, the ratio of observed cases of coronary heart disease to those expected, the resulting fraction multiplied by 100. The expected numbers of cases were determined by applying the agesex-specific disease rates observed in the whole population to the subgroups under consideration. This procedure corrects for possible bias resulting from differences in age composition that might occur in subjects classified into the different lipid quartiles.
In addition to determining the gradients of risk associated with the levels of the various lipids noted on the initial examination, risks of developing coronary heart disease associated with the lipid levels at each biennial examination and with the mean lipid level for the total periods of observation were determined, taking into account the person-years of exposure at various levels of the lipid. Details of the method of analysis have been published elsewhere (3).
RESULTS
In the 10 years of follow-up of the original study population of 5,127 men and women who were examined initially and found free of coronary heart disease, 219 men and 108 women have developed this disease under observation. The incidence rose with age in both men and women, with women achieving a comparable incidence 10 years later in life than the men (Figure 2) .
Examination of the distribution of the various lipids measured on the initial examination, both in those who have remained free of coronary heart disease for 10 years and in those who developed the disease in that period, revealed higher average levels in the disease-prone group, but a considerable overlapping of each distribution was noted (Figures 3, 4 , and 5). No lipid value places subjects clearly in one group and not the other. A sizeable proportion of those free of disease after 10 years are destined to develop it. Also, the majority of the population in this age group has long been recognized to be afflicted with coronary artery atherosclerosis. Lipids are believed to be related to development of coronary heart disease chiefly by virtue of their association with coronary artery atherosclerosis. It is, therefore, not reasonable to expect that lipids will dis-FIGURE 4. Distribution of S f 0-12 in subjects free of coronary heart disease versus those developing coronary heart disease in 10 years: men, 30 to 59 years at entry: Framingham Heart Study.
KANNEL ET AL.
Annals of Internal Medicine FIGURE 5. Distribution of phospholipid in subjects free of coronary heart disease versus those developing coronary heart disease in 10 years: men, 30 to 59 years at entry: Framingham Heart Study.
criminate with precision between those who have the disease and those who do not. Diagnosis of overt heart disease on the basis of lipid levels alone is simply not feasible.
However, estimation of the relative risk of developing the disease in association with various lipid levels is feasible and informative. This appears to be the most sensitive method of assessing the relative importance of various lipids and other factors in the development of coronary heart disease.
All three of the lipids under investigation have been demonstrated to be associated with risk of development of coronary heart disease. Comparison of the three types of lipids indicates that each is a reasonably good indicator of risk of coronary heart disease ( Figure 6 ). It will be noted that the risk rises with the lipid level and no sharp break-point or "critical" levels are noted in any of the lipids. The lack of a clear superiority of any one of the lipids under consideration as a predictor of coronary heart disease can be understood when note is taken of the reasonably high correlation between the various lipids ( Table 2) .
As a result of efforts to work out the details of the relationships of lipids to the development of coronary heart disease, a battery of lipids and lipid indexes has been jects with one lipid "abnormality'' by requiring more than one lipid to be elevated (Figure 7) .
Comparison of the gradients of risk of developing coronary heart disease associated with the various lipid indexes indicates that none are associated with a significantly steeper gradient than is cholesterol alone (Figure 8 ), although the "atherogenic index" appeared to be at least as good. The C/P ratio with or without consideration of uric acid level was not of use in estimating risk. This ratio is made up of two highly correlated lipids, both of which are be of pathogenetic importance in the development of coronary heart disease. Among the beta-lipoproteins, those that correlate best with the serum cholesterol level (S f 0-20) and carry the greater proportion of the total cholesterol appear to be associated with the steepest gradients of risk of development of coronary heart disease ( Figure 9 ). This is consistent with the hypothesis that the role of the lipoproteins in development of coronary heart disease is related to the amount of cholesterol carried by these lipoprotein vehicles. Comparison of the independent contribution of each of the lipids to risk of the development of coronary heart disease consistently ranks the serum cholesterol as the most important contributor ( Table 3) . The serum cholesterol level appears to be the best of all the lipids in discriminating those who developed the disease from those who did not.
Thus, it appears that with regard to lipids, almost all of the information relative to estimation of risk of development of coronary heart disease may be contained in knowledge of the serum cholesterol level and very little is added by the additional knowledge of the other lipid levels under consideration. Since the serum cholesterol level appears to make the most significant contribution to risk of development of coronary heart disease, the relationship of cholesterol to development of disease was examined in more detail.
As previously noted, the risk of development of coronary heart disease is related to the level of cholesterol in the blood, and no sharp break-point or critical level is apparent. The absence of a critical level can be illustrated by the presence of a gradient of risk of development of the disease, particularly myocardial infarction, in those with below "average" (225 mg/100 ml) cholesterol levels ( Figure 10) .
A sex difference is noted in the relationship between the serum cholesterol level and development of coronary heart disease. A gradient of risk is noted in men of all ages, but only in women under 50 does there appear to be a trend. Even this is not statistically significant with the numbers available ( Figure 11 ). FIGURE 13. Risk of "immediate mortality" in initial "heart attacks" according to antecedent mean cholesterol levels: men and women, 30 to 69 years: Framingham Heart Study. The risk of sudden death, a dramatic manifestation of coronary heart disease, also may be greater with an "elevated" serum cholesterol level (Figure 12 ).
In addition, the "immediate mortality" (within 3 weeks) after the occurrence of a "heart attack" was related to the antecedent serum cholesterol level (Figure 13) .
Cholesterol proved to be a good indicator of risk of development of coronary heart disease regardless of the measure of the cholesterol experience used. Persons classified according to their initial level, the mean level over the 10 years of observation or the level noted at the beginning of each biennial examination, all showed similar gradients of risk of development of the disease (Table 4) . Despite the alleged variability of cholesterol levels, it is quite FIGURE 14. Risk of developing coronary heart disease in 10 years in subjects with "low" and "elevated" serum cholesterol levels at specified blood pressure levels: men, 30 to 59 years at entry: Framingham Heart Study. possible to place subjects into risk categories with reasonable precision with one sample, provided in the laboratory determination of the lipid is reliable.
At the levels of serum cholesterol noted in this population, however, cholesterol could not be demonstrated to be a necessary or sufficient cause of coronary heart disease. The disease must be looked upon as resulting from the interplay of multiple inter-related factors.
The significance of any serum cholesterol level becomes more ominous when associated with other factors of risk. The risk appears to be compounded by elevation of blood pressure. For any given level of serum cholesterol the risk rises progressively with the blood pressure. This is consistent with the perfusion hypothesis of atherosclerosis (Figure 14) .
If, in addition to elevation of the blood FIGURE 16. Risk of developing "heart attacks" in 10 years according to combinations of specified "abnormalities": men, 30 to 59 years at entry: Framingham Heart Study. While uncertainty exists concerning the mechanism of regulation of lipids in the blood, the major cause of elevated lipid levels and the range of "normal values," the association between high blood lipid levels and development of coronary heart disease has been clearly demonstrated. While exception may be taken to one or more points, the aggregate of evidence is quite convincing, and doubts and skepticism hardly seem justified. Patients with clinically overt coronary heart disease have been shown to have on the average, higher cholesterol, beta-lipoprotein and phospholipid levels than suitable controls. Populations with high reported death rates from coronary heart disease have been reported to have higher mean serum cholesterol levels. Diseases associated with high serum lipid levels have been shown to be also associated with premature and excessive development of atherosclerotic diseases. The inducement of hyperlipemia in various animals has been shown to result in development of atherosclerotic lesions. Prospective studies have shown, with almost monotonous regularity, that subjects with elevated serum cholesterol levels develop more coronary heart disease than their cohorts with lower concentrations. Reasonable pathogenetic mechanisms have been proposed. Lipids found in the early atherosclerotic plaque bear a remarkable resemblance in kind and in relative proportions to those in the blood. At any level of cholesterol in the blood, the incidence of coronary heart disease rises with the blood pressure. This is quite consistent with the simple perfusion hypothesis of atherogenesis.
It is conceivable that cholesterol may not prove to be the lipid most central to the atherosclerotic process but as cholesterol goes, so go the other lipids. Thus far, no other lipid has been shown in prospective studies to be a better predictor of coronary heart disease, or to be associated with a higher risk of developing the disease. It remains for other lipids such as the triglycerides and nonesterified fatty acids to be tested prospectively. Also, whether the concentration of the various lipids or how they are partitioned among the lipoprotein vehicles is more important requires further investigation.
SUMMARY AND CONCLUSIONS
The efficacy of several serum lipids (cholesterol, phospholipids, and beta-lipopro-teins) and indexes derived from them as predictors of coronary heart disease has been evaluated in a longitudinal prospective study being conducted at Framingham, Massachusetts, in a population sample of 5,127 men and women aged 30 to 60 years.
Risk of subsequent development of coronary heart disease has been estimated in subjects classified according to antecedent serum lipid levels and various derived lipid indexes. Comparison of lipids and lipid indexes was made based on classification of subjects according to quartiles of the distribution of each of the lipids in the population.
Of the lipids compared, cholesterol appeared to make the most significant independent contribution to risk of coronary heart disease. Most of the lipid information relative to risk of developing coronary heart disease appeared to be contained in a knowledge of the serum cholesterol level. Little advantage appeared to exist in obtaining batteries of lipids, or indexes derived from lipids, for the estimation of proneness to coronary heart disease.
Such variability as exists in serum cholesterol levels did not prevent classification of subjects into categories of risk of developing coronary heart disease based on one reliable serum cholesterol level.
No critical or "safe" level of serum cholesterol below which no further gradient of risk exists could be identified. Within the range of serum cholesterol levels noted in this population sample, a gradient of risk existed from the lowest to the highest serum cholesterol levels observed.
Risk of developing coronary heart disease at any serum cholesterol concentration increased with the blood pressure level.
Highly susceptible individuals with combinations of "elevated" cholesterol level and other risk factors can be detected by the practicing physician utilizing ordinary office procedures. SUMMARIO Le variabilitate que existe in le nivellos serai de cholesterol non preveniva le classification del subjectos in categorias de risco (de disveloppar morbo cardiac coronari) a base de un sol fidel valor de cholesterol serai.
II non esseva possibile identificar un critic (i.e. "salve") nivello de cholesterol infra le qual nulle gradiente de risco existe. Intra le spectro de nivellos serai de cholesterol notate in iste specimen de population, un gradiente de risco existeva ab le plus basse ad le plus alte valores observate.
Le risco del disveloppamento de morbo cardiac coronari a un date concentration de cholesterol serai cresceva con le nivello del tension de sanguine.
Altemente susceptibile individuos con combinationes de "elevate" nivellos de cholesterol e altere factores de risco pote esser detegite per le medico practic con le uso de ordinari methodos de sala de consulta.
